Search
Returning search results with filters:
Remove filter for
Type: Health professional risk communication
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 106 - 120 of 120 items.
XOFIGO® (radium Ra 223 dichloride) - Increased Incidence of Fractures and Trend for Increased Deaths with XOFIGO used in combination with abiraterone and prednisone/prednisolone
AlertHealth professional risk communication | 2018-11-08
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Nephritis
AlertHealth professional risk communication | 2018-09-18
Tromboject 1% and 3% (sodium tetradecyl sulfate) with Visible Particles - Update on the Use of Medical Grade Filters
AlertHealth professional risk communication | 2018-09-12
EpiPen (epinephrine USP) Auto-Injector - Interim Order allowing the importation of AUVI-Q in response to shortages of EpiPen and EpiPen Jr
AlertHealth professional risk communication | 2018-08-29
Tromboject 1% and 3% (sodium tetradecyl sulfate) with Visible Particles
AlertHealth professional risk communication | 2018-07-17
BLINCYTO (blinatumomab) and Benzyl Alcohol Toxicity for Pediatric Patients
AlertHealth professional risk communication | 2018-06-12
TIVICAY, TRIUMEQ and JULUCA (dolutegravir containing medicines) – Possible Risk of Neural Tube Defects
AlertHealth professional risk communication | 2018-06-07
Jamp-Glucose 50 and Jamp-Glucose 75 – Risk of False Negative Oral Glucose Challenge or Tolerance Test Results
AlertHealth professional risk communication | 2018-06-07
Barbed Sutures and the Potential Risk of Small Bowel Obstruction
AlertHealth professional risk communication | 2018-05-31
Several GlaxoSmithKline Inc. vaccines: Potential Risk of Underdosing
AlertHealth professional risk communication | 2018-05-01
Percutaneous Radiofrequency Ablation Catheter and the Potential Risk of Atrioesophageal Fistula
AlertHealth professional risk communication | 2018-04-16
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
AlertHealth professional risk communication | 2018-03-16
Shortage of Erwinase for Injection and Replacement with UK Labelled Stock
AlertHealth professional risk communication | 2018-02-27
TECENTRIQ (atezolizumab) - Risk of Myocarditis
AlertHealth professional risk communication | 2018-02-14
OFEV (nintedanib) - Risk of Drug-Induced Liver Injury and the Need for Regular Monitoring of Liver Function
AlertHealth professional risk communication | 2018-01-11